Genomics of Drug Sensitivity in Cancer |
FR-180204
|
Synonyms |
FR 180204, FR180204, ERK Inhibitor II
|
Targets |
ERK1, ERK2
|
Target pathway |
ERK MAPK signaling
|
PubCHEM ID |
11493598
|
Jsmol |
|
Download molecule |
11493598
|
PUBCHEM IUPAC INCHI |
InChI=1S/C18H13N7/c19-17-12-10-13(20-22-18(12)23-21-17)15-14-8-4-5-9-25(14)24-16(15)11-6-2-1-3-7-11/h1-10H,(H3,19,21,22,23)
|
Smiles |
N2(=NC1(=NNC(=C1C=C2C=3(C(=NN4(C=3C=CC=C4))C5(=CC=CC=C5)))N))
|
Cluster number |
70
|
calculated LogS |
-5,218
|
Molecular weight |
327,35
|
calculated LogP |
1,1184
|
H-Acceptors |
7
|
H-Donors |
2
|
Ro5 violations |
0
|
Druglikeness |
-0,68095
|
DrugScore |
0,216610620126024
|
Mutagenic |
low
|
Tumorigenic |
high
|
Reproductive Effective |
none
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,4352
|
Rat Acute Toxicity |
2,6022
|
Acute Oral Toxicity |
II
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability2 |
0,7223
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
0,476
|
AMES Toxicity |
AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Non-carcinogens
|
Carcinogens |
Danger
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
High CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-2,6415
|